Nanotechnology-based drug delivery for cancer

Technology in Cancer Research and Treatment

Volumn 4, Issue 4, 2005, Pages 407-416

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

And Gene therapy; Anticancer drugs; Cancer; Cancer therapy; Nanobiotechnology; Nanoparticles; Nanotechnology; Targeted drug delivery

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; 4 HYDROXYTAMOXIFEN; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; ALBUMIN; ANTIBODY; ANTIESTROGEN; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; BRACHYSIL; CAMPOSOMES; CAMPTOTHECIN; CANCER VACCINE; CARBON; CHOLESTEROL; CISPLATIN; CREMOPHOR; DENDRIMER; FOLIC ACID; GOLD; INGN 401; IRON; LIPID; LIPLASOME; LIPOSOME; MACROGOL; MELANOMA ANTIGEN 3; MONOCLONAL ANTIBODY; NANOPARTICLE; PACLITAXEL; PHOSPHOLIPID; POLYSACCHARIDE; PROTEIN; RECOMBINANT VACCINE; SILICON DIOXIDE; TAXOSOMES; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOTECHNOLOGY; CANCER; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL TRIAL; DEVICE; DRUG DELIVERY SYSTEM; DRUG HYPERSENSITIVITY; DRUG TARGETING; ENCAPSULATION; GENE THERAPY; HUMAN; NANOTECHNOLOGY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; REVIEW;

EID: 24144461213     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460500400408     Document Type: Review

References (36)

1. Jain, K. K. Nanobiotechnology: Applications, Markets and Companies. Jain PharmaBiotech Publications, Basel (2005). (http://pharmabiotech.ch/reports/ nanobiotechnology/).
2. Paciotti, G. F., Myer, L., Weinreich, D., et al. Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery. Drug Deliv. 11, 169-183 (2004).
3. Sun, Q., Wang, Q., Rao, B. K., Jena, P. Electronic Structure and Bonding of Au on a SiO2 Cluster: A Nanobullet for Tumors. Phys Rev Lett 93, 186803 (2004).
4. Gillies, E. R., Frechet, M. J. Dendrimers and Dendritic Polymers in Drug Delivery. DDT 10, 35-43 (2005).
5. Choi, Y., Baker, J. R. Jr. Targeting Cancer Cells with DNA-Assembled Dendrimers: A Mix and Match Strategy for Cancer. Cell Cycle 4, 669-671 (2005).
6. Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., et al. Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer. Cancer Research 65, 5317-5324 (2005).
7. Abraxane [Prescribing Information]. Schaumburg, Ill: Abraxis Oncology, a Division of American Pharmaceutical Partners Inc, January (2005).
8. Maillard, S., Ameller, T., Gauduchon, J., et al. Innovative Drug Delivery Nanosystems Improve the Anti-tumor Activity In Vitro and In Vivo of Anti-estrogens in Human Breast Cancer and Multiple Myeloma. J. Steroid. Biochem. Mol. Biol. 94, 111-121 (2005).
9. Wartlick, H., Spankuch-Schmitt, B., Strebhardt, K., et al. Tumour Cell Delivery of Antisense Oligonucleotides by Human Serum Albumin Nanoparticles. J. Control Release 96, 483-495 (2004).
10. Burger, K. N., Staffhorst, R. W., de Vijlder, H. C., et al. Nanocapsules: Lipid-coated Aggregates of Cisplatin with High Cytotoxicity. Nat. Med. 8, 81-84 (2002).
11. Taylor, D. D., Gercel-Taylor, C. Tumour-derived Exosomes and Their Role in Cancer-associated T-cell Signalling Defects. Br. J. Cancer 92, 305-311 (2005).
12. Escudier, B., Dorval, T., Chaput, N., et al. Vaccination of Metastatic Melanoma Patients with Autologous Dendritic Cell (DC) Derived-Exosomes: Results of the First Phase I Clinical Trial. J. Transl. Med. 3, 10 (2005).
13. Stella, B., Arpicco, S., Peracchia, M. T., et al. Design of Folic Acid-conjugated Nanoparticles for Drug Targeting. J. Pharm. Sci. 89, 1452-1464 (2000).
14. Xu, Z., Gu, W., Huang, J., et al. In vitro and In Vivo Evaluation of Actively Targetable Nanoparticles for Paclitaxel Delivery. Int. J. Pharm. 288, 361-368 (2005).
15. Ma, Y., Manolache, S., Denes, F. S., et al. Plasma Synthesis of Carbon Magnetic Nanoparticles and Immobilization of Doxorubicin for Targeted Drug Delivery. J. Biomater. Sci. Polym. Ed. 15, 1033-1049 (2004).
16. Farokhzad, O. C., Jon, S., N. Khademhosseini, A., et al. Nanoparticle-Aptamer Bioconjugates: A New Approach for Targeting Prostate Cancer Cells. Cancer Research 64, 7668-7672 (2004).
17. Williams, J., Lansdown, R., Sweitzer, R., et al. Nanoparticle Drug Delivery System for Intravenous Delivery of Topoisomerase Inhibitors. J. Control Release 91, 167-172 (2003).
18. Andresen, T. L., Davidsen, J., Begtrup, M., et al. Enzymatic Release of Antitumor Ether Lipids by Specific Phospholipase A2 Activation of Liposome-forming Prodrugs. J. Med. Chem. 47, 1694-1703 (2004).
19. Li, L., Wartchow, C. A., Danthi, S. N., et al. A Novel Antiangiogenesis Therapy Using an Integrin Antagonist or Anti-Flk-1 Antibody Coated 90Y-labeled Nanoparticles. Int. J. Radiat. Oncol. Biol. Phys. 58, 1215-1227 (2004).
20. Park, J. H., Kwon, S., Nam, J. O., et al. Self-assembled Nanoparticles Based on Glycol Chitosan Bearing 5beta-cholanic Acid for RGD Peptide Delivery. J. Control Release 95, 579-588 (2004).
21. Kreuter, J. Nanoparticulate Systems for Brain Delivery of Drugs. Adv. Drug. Deliv. Rev. 47, 65-81 (2001).
22. Gelperina, S. E., Khalansky, A. S., Skidan, I. N., et al. Toxicological Studies of Doxorubicin Bound to Polysorbate 80-coated Poly(butyl cyanoacrylate) Nanoparticles in Healthy Rats and Rats with Intracranial Glioblastoma. Toxicol. Lett. 126, 131-141 (2002).
23. Zhang, Y., Sun, C., Kohler, N., et al. Self-Assembled Coatings on Individual Monodisperse Magnetite Nanoparticles for Efficient Intracellular Uptake. Biomedical Microdevices 6, 33-40 (2004).
24. Steiniger, S. C., Kreuter, J., Khalansky, A. S., et al. Chemotherapy of Glioblastoma in Rats Using Doxorubicin-loaded Nanoparticles. Int. J. Cancer 109, 759-767 (2004).
25. Wu, G., Barth, R. F., Yang, W., et al. Site-specific Conjugation of Boron-containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture Therapy. Bioconjug. Chem. 15, 185-194 (2004).
26. Dichtel, W. R., Serin, J. M., Edder, C., et al. Singlet Oxygen Generation via Two-photon Excited FRET. J. Am. Chem. Soc. 126, 5380-5381 (2004).
27. Roy, I., Mitra, S., Maitra, A., Mozumdar, S. Calcium Phosphate Nanoparticles as Novel Non-viral Vectors for Targeted Gene Delivery. Int. J. Pharm. 250, 25-33 (2003).
28. Hilger, I., Hiergeist, R., Hergt, R., et al. Thermal Ablation of Tumors using Magnetic Nanoparticles: An In Vivo Feasibility Study. Invest. Radiol. 37, 580-586 (2002).
29. Ito, A., Kuga, Y., Honda, H., et al. Magnetite Nanoparticle-loaded Anti-HER2 Immunoliposomes for Combination of Antibody Therapy with Hyperthermia. Cancer Lett. 212, 167-175 (2004).
30. Larina, I. V., Evers, B. M., Ashitkov, T. V., et al. Enhancement of Drug Delivery in Tumors by Using Interaction of Nanoparticles with Ultrasound Radiation. Technol. Cancer Res. Treat. 4, 217-226 (2005).
31. Prabha, S., Labhasetwar, V. Nanoparticle-Mediated Wild-Type p53 Gene Delivery Results in Sustained Antiproliferative Activity in Breast Cancer Cells. Molecular Pharmaceutics 1, 211-219 (2004).
32. Ito, I., Ji, L., Tanaka, F., et al. Liposomal Vector Mediated Delivery of the 3p FUS1 Gene Demonstrates Potent Antitumor Activity Against Human Lung Cancer In Vivo. Cancer Gene Therapy 11, 733-739 (2004).
33. Gopalan, B., Ito, I., Branch, C. D., et al. Nanoparticle Based Systemic Gene Therapy for Lung Cancer: Molecular Mechanisms and Strategies to Suppress Nanoparticle-Mediated Inflammatory Response. Technology in Cancer Research & Treatment 3, 647-648 (2004).
34. Hirsch, L. R., Stafford, R. J., Bankson, J. A., et al. Nanoshell-mediated Near-infrared Thermal Therapy of Tumors Under Magnetic Resonance Guidance. PNAS 100, 13549-13554 (2003).
35. Loo, C., Lowery, A., Halas, N., West, J., Drezek, R. Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy. Nano. Lett. 5, 709-711 (2005).
36. Schmieder, A. H., Winter, P. M., Caruthers, S. D., et al. Molecular MR Imaging of Melanoma Angiogenesis with anb3-targeted Paramagnetic Nanoparticles. Magnetic Resonance in Medicine 53, 621-627 (2005).